THC Biomed Intl Ltd.
THCBF
$0.00
$0.000.00%
OTC PK
| 04/30/2023 | 01/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -37.63% | 6.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -37.63% | 6.33% | |||
| Cost of Revenue | -23.84% | 152.34% | |||
| Gross Profit | 1.33% | -303.82% | |||
| SG&A Expenses | -7.40% | 35.41% | |||
| Depreciation & Amortization | -10.43% | -0.82% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.98% | 77.65% | |||
| Operating Income | 5.74% | -204.91% | |||
| Income Before Tax | 6.18% | -195.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.18% | -195.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.18% | -195.46% | |||
| EBIT | 5.74% | -204.91% | |||
| EBITDA | 4.44% | -347.44% | |||
| EPS Basic | 6.67% | -200.00% | |||
| Normalized Basic EPS | 7.14% | -211.11% | |||
| EPS Diluted | 6.67% | -200.00% | |||
| Normalized Diluted EPS | 7.14% | -211.11% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||